首页> 美国卫生研究院文献>Pharmaceutics >Relative Contributions of Solubility and Mobility to the Stability of Amorphous Solid Dispersions of Poorly Soluble Drugs: A Molecular Dynamics Simulation Study
【2h】

Relative Contributions of Solubility and Mobility to the Stability of Amorphous Solid Dispersions of Poorly Soluble Drugs: A Molecular Dynamics Simulation Study

机译:溶解性和流动性对难溶性药物非晶态固体分散体稳定性的相对贡献:分子动力学模拟研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Amorphous solid dispersions are considered a promising formulation strategy for the oral delivery of poorly soluble drugs. The limiting factor for the applicability of this approach is the physical (in)stability of the amorphous phase in solid samples. Minimizing the risk of reduced shelf life for a new drug by establishing a suitable excipient/polymer-type from first principles would be desirable to accelerate formulation development. Here, we perform Molecular Dynamics simulations to determine properties of blends of eight different polymer–small molecule drug combinations for which stability data are available from a consistent set of literature data. We calculate thermodynamic factors (mixing energies) as well as mobilities (diffusion rates and roto-vibrational fluctuations). We find that either of the two factors, mobility and energetics, can determine the relative stability of the amorphous form for a given drug. Which factor is rate limiting depends on physico-chemical properties of the drug and the excipients/polymers. The methods outlined here can be readily employed for an in silico pre-screening of different excipients for a given drug to establish a qualitative ranking of the expected relative stabilities, thereby accelerating and streamlining formulation development.
机译:无定形固体分散体被认为是用于口服递送难溶性药物的有前途的制剂策略。该方法适用性的限制因素是固体样品中非晶相的物理(不稳定性)。通过根据第一原理建立合适的赋形剂/聚合物类型来最大程度地减少新药降低保质期的风险,这将加速制剂开发。在这里,我们进行分子动力学模拟,以确定八种不同的聚合物-小分子药物组合的共混物的性质,其稳定性数据可从一组一致的文献数据中获得。我们计算热力学因素(混合能量)和迁移率(扩散率和旋转振动波动)。我们发现,流动性和能量学这两个因素中的任何一个都可以确定给定药物的无定形形式的相对稳定性。哪个因素是速率限制,取决于药物和赋形剂/聚合物的物理化学性质。本文概述的方法可轻松用于给定药物的不同赋形剂的计算机模拟预筛选,以建立预期相对稳定性的定性排名,从而加速和简化制剂开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号